Latest filing published 15 Jun 2021 for Sientra, Inc..
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nicholas Simon: trading record in brief
Nicholas Simon (board member) discloses dealings in 3 companies, chiefly Sientra, Inc., Achillion Pharmaceuticals Inc and Gritstone bio, Inc. In total, 10 filings cover trades dated from 4 June 2012 to 10 June 2021.
The open-market record is one-sided, with 1 purchase worth €4.3M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants.
On 15 June 2021 came the latest disclosure, a share grant in Sientra, Inc. The clock since the last published purchase (2 October 2018) now reads 2,960 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicholas Simon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,870 shares0Common StockSEC:0001209191-21-040772:0
- 27,717 shares0Common Stock (RSUs)SEC:0001209191-20-035384:0
- 19,320 shares0Common Stock (RSUs)SEC:0001209191-19-037846:0
- 2,234,112 sharesCommon StockSEC:0001567619-18-003534:1
- 333,333 shares@ US$15.00100.0% of flowCommon StockSEC:0001567619-18-003534:0Canonical exit: 27 Dec 2018 (T+90)
- 6,116 shares@ US$20.4432.4% of flowCommon Stock (RSUs)SEC:0001209191-18-036541:0
- 12,861 shares@ US$9.7234.1% of flowCommon StockSEC:0000899243-17-017257:0
- 18,685 shares@ US$6.6933.5% of flowCommon StockSEC:0001179110-16-026963:0
- 22,078 shares0Common StockSEC:0001012975-12-000197:1
- 51,515 shares0Common StockSEC:0001012975-12-000197:0
10 of 9 declarations